Should I Start TRT With a Testosterone of 762? (TRT Q&As)
Timeline
A 39-year-old man reports trouble focusing, poor energy and recovery, and reduced stamina despite a total testosterone of 762. Dr. O’Connor says the situation is too complex to decide from testosterone numbers alone and also flags his elevated PSA and LDL for further evaluation before considering TRT.
Dr. O’Connor explains that recurrent gout and elevated uric acid deserve proper medical management rather than relying on supplements or diet alone. He recommends evaluation by an appropriate physician, potentially a rheumatologist, and stresses controlling uric acid and monitoring kidney health.
A 41-year-old man reports blood pressure around 177/119 and hyperaldosteronism. Dr. O’Connor considers this potentially consistent with Conn syndrome and strongly emphasizes evaluation by a hypertension specialist because an adrenal cause may require specialized testing and potentially surgical treatment.
A 34-year-old man with low total and free testosterone asks about using HCG and Clomid to avoid TRT. Dr. O’Connor says the regimen may have a role in fertility management but questions its practicality as a permanent solution and recommends a more individualized evaluation.
Dr. O’Connor says testosterone and Deca can make men feel good but emphasizes that combined androgen exposure can adversely affect blood pressure, cholesterol, the heart, red blood cells, and iron-related markers. He recommends keeping exposure low and closely monitoring cardiovascular and hematologic health.
A 43-year-old long-term TRT user and competitive bodybuilder reports bilateral echogenic kidneys and a kidney cyst on ultrasound despite reassuring blood work. Dr. O’Connor discusses the multiple ways long-term steroid exposure can contribute to kidney stress and recommends a thorough kidney evaluation with a nephrologist, potentially including more detailed assessment of renal function and proteinuria.
Video Summary
This mailbag discussion focuses on questions about injection timing during testosterone therapy, particularly weekly scheduling and spacing. It explains how timing consistency influences symptom stability and lab interpretation. Injection schedules are framed as tools for predictability rather than rigid rules.
A central portion discusses how missed or shifted injection days can create short-term symptom changes. The episode emphasizes understanding pharmacologic timing rather than reacting to transient sensations. Contextual awareness is highlighted.
The closing segment reinforces the value of routine scheduling in long-term testosterone management. Planning, flexibility within structure, and expectation alignment are emphasized. Hormone therapy is positioned as benefiting from consistency over perfection.
Drug Callouts
Condition Callouts
Key Takeaways
- Injection timing influences short-term symptom stability.
- Weekly scheduling supports predictable response.
- Delayed injections can create transient changes.
- Contextual interpretation prevents overreaction.
- Consistency supports long-term management.